Introduction {#sec1}
============

Synthesis of diverse heterocycles using readily available starting materials is everlasting aim of synthetic organic chemistry. Especially in recent years, under the inspiration of step economy, the use of cascade reactions to achieve target products is attracting increasing attention. In this context, tandem reactions which allow multiple chemical transformations in one pot have been recognized as a rather valuable strategy in realizing organic synthesis with high efficiency.^[@ref1]^ Because of these significant advantages, tandem reactions have been a popular strategy for the rapid synthesis of small molecules, especially in the synthesis of drug like structures and natural products.^[@ref2]^

Multisubstituted furans signify one of the important classes of five-membered heterocycles prevalent in natural products, pharmaceuticals, and agrochemicals and also represent useful intermediates in organic synthesis.^[@ref3]^ Consequently, a number of synthetic routes for the construction of polysubstituted furans have been reported, such as direct functionalization of furan rings,^[@ref4]^ Paal--Knorr synthesis,^[@ref5]^ Feist--Benary synthesis,^[@ref6]^ and metal-catalyzed cycloisomerization of alkynyl or allenyl substrates.^[@ref7]^ However, the investigation of innovative methods for the generation of polyfunctionalized furans is still highly desirable. One of the core concepts involves the Wittig reaction between α-substituted chalcones (generated from aldehydes) and acyl chlorides using a combination of reagents ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a).^[@ref8]^ In an effort to develop such a system, we hypothesized that the reaction of aroylacetonitrile **1** with 2-oxoaldehydes (OAs) **2** under triethylamine (TEA)--*tert*-butyl hydroperoxide (TBHP) combination in one pot will result in the synthesis of 3-cyanofurans, through an in situ generated 1,4-dione **A** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b).^[@ref9]^ However, an unprecedented reaction between **1** and **2** under TEA--TBHP resulted in the synthesis of Z-selective highly functionalized polysubstituted furans that are difficult to be accessed by other protocols ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}c). In this context, we wish to present a new type of one-pot tandem reaction between aroylacetonitriles and OAs for the generation of diverse functionalized 3-hydroxy-2-furanyl-acrylamides. The salient feature of this reaction represents the TEA--TBHP-promoted dual addition of acetonitriles against OAs.

![Synthesis of Highly Functionalized Furans via a One-Pot Tandem Reaction](ao-2018-00715v_0003){#sch1}

Results and Discussion {#sec2}
======================

We commenced our study by investigating the reaction of benzoylacetonitrile **1a** (1 mmol), phenylglyoxal **2a** (1 mmol), morpholine (0.5 mmol), and TBHP (1.1 mmol) in toluene at 70 °C (entry 1, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). To our delight, the reaction furnished the desired furan **3a** in 54% yield and phenylglyoxylicacid **4a** as a byproduct. Following the promising results achieved with the above method, the reaction conditions, particularly, the change in base, concentrations, and temperature were investigated (entries 2--23). Preliminarily, a survey of change in base (entries 1--6) intimated that best results were observed with 0.5 mmol of TEA (entry 6). Besides, screening of our reaction at different concentrations of TEA and TBHP was also performed (entries 7--12). We observed that any change in the concentration of base/TBHP resulted in a decrease of **3a**. However, in the absence of TEA and TBHP, we found no reaction (entries 10 and 12). Furthermore, a survey of change in temperature (entries 13--16) intimated that the yields were drastically affected by the increase/decrease in the reaction temperature. Reaction of **1a** with **2a** in most of the solvents (entries 17--21) at 70 °C failed to produce **3a** in good yields (except for the reaction in CHCl~3~). Finally, two different reactions when tested against different oxidants confirmed the role of TBHP to promote our reaction (entries 22--23). In addition, we also studied the effect of change in concentration of **2a** and TBHP on reaction yields ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00715/suppl_file/ao8b00715_si_001.pdf), page SI3). It was quite evident that the increase in the concentration of TBHP or the change in the optimal concentration of **2a** led to formation of byproducts and hence resulted in lower yields of **3a**. After optimization studies, we observed that the paramount conditions for the reaction were when 1 mmol of **1a** was treated with 1 mmol of **2a**, 0.5 mmol of TEA, and 1.1 mmol of TBHP in 2 mL of toluene at 70 °C (entry 3).

###### Optimization for the Synthesis of Functionalized 3-Hydroxy-2-furanyl-acrylamides[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-00715v_0004){#GRAPHIC-d7e334-autogenerated}

  entry   base (mmol)        oxidant (mmol)   solvent   temp (°C)   yield **3a** (%)[b](#t1fn2){ref-type="table-fn"}
  ------- ------------------ ---------------- --------- ----------- --------------------------------------------------
  1       morpholine (0.5)   TBHP (1.1)       toluene   70          54
  2       piperidine (0.5)   "                "         "           35
  3       DBU (0.5)          "                "         "           39
  4       DABCO (0.5)        "                "         "           28
  5       DMAP (0.5)         "                "         "           10
  6       TEA (0.5)          "                "         "           76
  7       TEA (0.3)          "                "         "           45
  8       TEA (0.1)          "                "         "           25
  9       TEA (1.0)          "                "         "           15
  10                         "                "         "            
  11      TEA (0.5)          TBHP (0.5)       "         "           35
  12      "                                   "         "            
  13      "                  TBHP (1.1)                 80          71
  14      "                  "                "         90          43
  15      "                  "                "         60          23
  16      "                  "                "         rt           
  17      "                  "                dioxane   70          trace
  18      "                  "                CHCl~3~   "           30
  19      "                  "                DMF       "            
  20      "                  "                MeOH      "            
  21      "                  "                MeCN      "            
  22      "                  TEMPO (1.1)      toluene   "            
  23      "                  IBX (1.1)        toluene   "            

Reaction conditions: benzoylacetonitrile **1a** (1.0 mmol), phenylglyoxal **2a** (1.0 mmol) and TEA (0.5 mmol), 5--6 M TBHP in decane (1.1 mmol) in toluene at 70 °C.

Isolated yield.

The structure and the Z-selectivity of our reactions were confirmed by the single-crystal X-ray diffraction studies of **3n** and **3f** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}; for details, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00715/suppl_file/ao8b00715_si_001.pdf), pages SI5--SI11). The packing diagram of **3n** viewed down along the α-axis of the unit cell clearly features one intramolecular classical O--H···O hydrogen bond between hydroxyl and carbonyl O atoms leading to a self-associated motif. Furthermore, the crystal structure is stabilized by classical N--H···N hydrogen bonds (between amide and cyanide groups) and nonclassical weak intermolecular C--H···O interactions.

![ORTEP and packing diagrams viewed down along the α-axis of the unit cell of **3n**.](ao-2018-00715v_0001){#fig1}

With the optimized reaction condition in hand, we next investigated the substrate scope ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). In one set of experiments, different reactions were performed between benzoylacetonitrile **1a** and OAs **2** (entries **3a--3l**). Various aromatic OAs proceeded well in this process, and valuable functional groups such as chloro, bromo, fluoro, CF~3~, hydoxy, methyl, ethyl, and nitro were tolerated. Furthermore, substituents at different positions of the arene group and their electronic nature do not affect the efficiency of the reaction to that extent, even though we observed comparatively lower yields with electron-withdrawing groups (entries **3e** and **3f**). Another set of experiments were performed between different acetonitriles **1** and phenylglyoxal **2a** (entries **3m--3p**) for the preparation of different furans **3**. Yields were generally good for all tested reactions. After having established the scope of the reaction, a small library of different 3-hydroxy-2-furanyl-acrylamides were also produced by assembling the building blocks shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} (entries **3q--3u**).

###### Substrate Scope for the Functionalized 3-Hydroxy-2-furanyl-acrylamides[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-00715v_0005){#GRAPHIC-d7e751-autogenerated}

![](ao-2018-00715v_0006){#gr4}

Reaction conditions: **1** (0.689 mmol), **2** (0.689 mmol), and TEA (0.344 mmol), 5--6 M TBHP in decane (0.758 mmol) in toluene at 70 °C.

Isolated yield.

Further, we proposed to extend the application of our method toward the generation of different 2-heteroarylfurans, which may be useful in medicinal or materials science.^[@ref10]^ This characteristic feature of the reaction could be helpful to generate different valuable structures, which otherwise are difficult to be generated through previous approaches.^[@ref4]−[@ref8]^ In all of these presumptions, the nature of heteroarylglyoxals **2** decides the fate of the furan-heteroaryl coupling product. For instance, different reactions tested between aroylacetonitriles **1** and 2-thiopheneglyoxals **2** resulted in the generation of different 2-(thiophen-2-yl)furans (entries **3v--3aa**, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). We were gratified to find that in all tested reactions, the desired products **3** were isolated in appreciable yields (46--65%).

###### Substrate Scope for the Functionalized 2-(Thiophen-2-yl)-furans[a](#t3fn1){ref-type="table-fn"}

![](ao-2018-00715v_0007){#GRAPHIC-d7e809-autogenerated}

![](ao-2018-00715v_0008){#gr5}

Reaction conditions: **1** (0.689 mmol), **2** (0.689 mmol), and TEA (0.344 mmol), 5--6 M TBHP in decane (0.758 mmol) in toluene at 70 °C.

Isolated yield.

In order to investigate the mechanism of synthesis of (*Z*)-2-furanyl-acrylamides, different controlled experiments were performed ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a). Experiment 1, conducted between **1b** with **2a** in the presence of free-radical scavenger (TEMPO, 4 equiv) under the optimized conditions, resulted in the synthesis of **3m** in comparable yields, thereby excluding the possibility of free-radical pathway. Our reaction when performed in the presence of either TBHP or TEA (experiments 2 and 3) failed to produce the desired product **3m**. These two results demonstrate that the second addition/cyclization to **3m** involves participation of both the reagents. Further, the reaction of phenylglyoxal in the presence of TBHP in toluene at 70 °C generated acid **5** in good yields (experiment 4). These findings along with the optimization observation "entry 3 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, isolation of oxoacid **4a**)" undoubtedly emphasize the role of in situ generated acid in the Paal--Knorr cyclization and the consumption of half mole of oxoaldehydes in our reaction. In continuation, we performed a reaction between intermediate **6**([@ref9]) and toluoylacetonitrile under optimized conditions in the presence of 2-oxoacid **5** (experiment 5). The formation of the desired product in comparable yields pointed toward the participation of Michael acceptor **A** in the reaction. Finally, the failure of reaction with aliphatic glyoxal/acetonitrile under the described conditions justifies the participation of the aryl group in the activation of intermediate **A** (experiment 6).

![(a) Control experiment and (b) plausible mechanism.](ao-2018-00715v_0002){#fig2}

On the basis of the preceding literature reports^[@ref5]^ and the abovementioned results, a plausible reaction mechanism is proposed in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b. The initial step for the synthesis of 3-hydroxy-2-furanyl-acrylamides **3** involves the reaction of aroylacetonitrile **1** and OA **2** under a basic environment to form Knoevenagel adduct or Michael acceptor **A**. This intermediate under a TEA--TBHP environment undergoes second addition of aroylacetonitrile **1** to a symmetric resonance-stabilized Michael adduct **B**. Intermediate **B** in the presence of in situ generated 2-oxoacid and TBHP experiences monoamidation to **C**. Finally, it undergoes the intramolecular Paal--Knorr cyclization to required 3-hydroxy-2-furanyl-acrylamides **3**.

Conclusions {#sec3}
===========

We have outlined a new one-pot tandem approach for the generation of 3-hydroxy-2-furanyl-acrylamides **3** through an unprecedented reaction between aroylacetonitrile **1** and OA **2** under a TEA--TBHP environment. Despite the variation in the nature of **1** and **2**, the furans generated had a functional core structure with Z-selective C-2 acrylamides. These protocols also provided applications toward the generation of different 2-heteroarylfurans in good yields. The stability of Z-isomer in each case was attributed to the characteristic intramolecular classical O--H···O hydrogen bond between hydroxyl and carbonyl O atoms that led to self-associated (*Z*)-2-furanyl-acrylamides.

Experimental Section {#sec4}
====================

General Experiments {#sec4.1}
-------------------

All chemicals used were of commercial grade and were used as such. ^1^H NMR and ^13^C NMR spectra were recorded on 500 and 400 MHz instruments. Chemical data for protons and carbons were reported in parts per million (ppm) downfield from tetramethylsilane and are referenced to the residual proton and carbon in the NMR solvents (CDCl~3~: 7.26 ppm, ^13^C NMR solvents CDCl~3~: 77.0, acetone-*d*~6~: 206.6, 29.9 ppm). Electrospray ionization mass spectrometry (ESI-MS) and high-resolution mass spectrometry (HRMS) spectra were recorded on Agilent 1100 LC-Q-TOF and HRMS-6540-UHD machines. IR spectra were recorded on an FTIR spectrophotometer with the absorption band given in cm^--1^. Melting points were measured in a digital melting point apparatus.

General Procedure for the Synthesis of (*Z*)-2-(4-Cyano-furanyl)-3-hydroxy-acrylamides **3** {#sec4.2}
--------------------------------------------------------------------------------------------

To a 25 mL round bottomed flask equipped with a magnetic bar, aroylacetonitrile **1** (0.689 mmol), arylglyoxal monohydrate **2** (0.689 mmol) were dissolved in 2 mL of toluene then added TEA (0.344 mmol) and TBHP in decane (0.754 mmol). The reaction mixture was stirred at 75 °C for 4--6 h. To determine the status of the reaction, it was monitored by thin-layer chromatography. After completion, the reaction mixture was cooled to room temperature, and 15 mL of water was added to the reaction mixture and extracted with ethyl acetate (2 × 15 mL). The combined organic layer was washed with brine solution, dried over Na~2~SO~4~, concentrated on a rotavap, and purified by column chromatography by using ethyl acetate and hexane (1:4), producing desired product **3** in good yields (45--76%).

Analytical Data for Compounds **3** {#sec4.3}
-----------------------------------

### (*Z*)-2-(4-Cyano-2,5-diphenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3a** {#sec4.3.1}

White solid (106 mg, 76% yield). mp 235--238 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.75 (s, 1H), 8.00 (d, *J* = 8.0 Hz, 2H), 7.85 (d, *J* = 7.2 Hz, 2H), 7.49--7.45 (m, 5H), 7.42--7.38 (m, 3H), 7.29 (t, *J* = 7.2 Hz, 1H), 7.21 (t, *J* = 8.0 Hz, 2H), 5.51 (s, 2H). ^13^C NMR (125 MHz, CDCl~3~): δ 174.9, 173.2, 158.3, 150.2, 134.5, 130.6, 130.4, 129.3, 129.2, 129.2, 128.4, 128.1, 128.0, 127.4, 125.4, 125.0, 117.5, 113.4, 97.0, 91.3. IR (CHCl~3~, cm^--1^) ν: 3468, 3360, 2923, 2851, 2226, 1641, 1489, 1445, 1415, 1330, 1156, 937, 768, 689. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~N~2~O~3~, 407.1; found, 407.1; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~N~2~O~3~, 407.1390; found, 407.1375.

### (*Z*)-2-(2-(4-Chlorophenyl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3b** {#sec4.3.2}

White solid (105 mg, 70% yield). mp 225--228 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.75 (s, 1H), 8.00 (d, *J* = 8.0 Hz, 2H), 7.76 (d, *J* = 8.8 Hz, 2H), 7.51 (m, 3H), 7.44 (d, *J* = 8.4 Hz, 2H), 7.36 (d, *J* = 7.2 Hz, 2H), 7.30 (t, *J* = 7.2 Hz, 1H), 7.22 (d, *J* = 7.6 Hz, 2H), 5.47 (s, 2H). ^13^C NMR (100 MHz, CDCl~3~): δ 175.2, 173.3, 158.6, 149.3, 135.4, 134.4, 131.5, 130.7, 130.5, 129.5, 129.2, 128.8, 128.1, 127.9, 127.3, 126.8, 126.2, 125.4, 117.9, 113.2, 97.2, 91.0. IR (CHCl~3~, cm^--1^) ν: 3359, 3063, 2955, 2923, 2852, 2227, 1691, 1648, 1573, 1490, 1447, 1403, 1326, 1277, 1180, 1094, 1013, 937, 832, 770, 691, 606. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~ClN~2~O~3~, 441.1; found, 441.1; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~ClN~2~O~3~, 441.1000; found, 441.0926.

### (*Z*)-2-(2-(4-Bromophenyl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3c** {#sec4.3.3}

White solid (120 mg, 72% yield). mp 263--266 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.76 (s, 1H), 8.01 (d, *J* = 8.4 Hz, 2H), 7.70 (d, *J* = 8.4 Hz, 2H), 7.60 (d, *J* = 8.4 Hz, 2H), 7.52--7.47 (m, 3H), 7.37 (d, *J* = 6.8 Hz, 2H), 7.31 (t, *J* = 7.2 Hz, 1H), 7.23 (t, *J* = 7.2 Hz, 2H), 5.44 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.2, 173.2, 158.1, 149.3, 132.4, 130.7, 130.4, 129.2, 128.1, 127.8, 127.3, 126.4, 125.4, 123.6, 118.1, 113.2, 97.3, 91.0. IR (CHCl~3~, cm^--1^) ν: 3404, 2922, 2852, 2228, 1648, 1572, 1446, 1416, 1327, 1145, 938, 828, 768, 691. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~BrN~2~O~3~, 485.1, 487.1; found, 485.1, 487.1; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~BrN~2~O~3~, 485.0495, 487.0479; found, 485.0498, 487.0482.

### (*Z*)-2-(4-Cyano-2-(4-fluorophenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3d** {#sec4.3.4}

White solid (95 mg, 65% yield). mp 222--235 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.74 (s, 1H), 8.01 (d, *J* = 8.0 Hz, 2H), 7.81 (dd, *J* = 5.2, 3.2 Hz, 2H), 7.52--7.47 (m, 3H), 7.37 (d, *J* = 7.2 Hz, 2H), 7.31 (t, *J* = 6.4 Hz, 1H), 7.23--7.14 (m, 4H), 5.56 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.2, 173.4, 158.4, 149.6, 134.5, 130.6, 130.4, 129.2, 128.0, 127.8, 127.4, 127.2, 127.1, 125.4, 117.1, 116.5, 116.2, 113.3, 97.1, 91.1. IR (CHCl~3~, cm^--1^) ν: 3346, 3198, 2924, 2852, 2227, 1643, 1594, 1504, 1445, 1415, 1328, 1236, 1159, 938, 838, 768, 689. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~FN~2~O~3~, 425.0; found, 425.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~FN~2~O~3~, 425.1296; found, 425.1299.

### (*Z*)-2-(4-Cyano-5-phenyl-2-(4-(trifluoromethyl)phenyl)furan-3-yl)-3-hydroxy-3-phenylacryl amide **3e** {#sec4.3.5}

Pale yellow solid (89 mg, 55% yield). mp 238--241 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.78 (s, 1H), 8.04 (d, *J* = 8.0 Hz, 2H), 7.94 (d, *J* = 8.0 Hz, 2H), 7.73 (d, *J* = 8.4 Hz, 2H), 7.54--7.50 (m, 3H), 7.36 (d, *J* = 6.4 Hz, 2H), 7.32 (t, *J* = 7.6 Hz, 1H), 7.23 (t, *J* = 7.6 Hz, 2H), 5.52 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.4, 173.1, 159.2, 148.7, 134.4, 131.0, 130.5, 129.3, 128.1, 127.8, 127.1, 126.19, 126.15, 126.11, 125.5, 125.1, 119.6, 113.0, 97.4, 90.8. IR (CHCl~3~, cm^--1^) ν: 3347, 3198, 2921, 2851, 2228, 1647, 1554, 1490, 1324, 1236, 1124, 939, 829, 768, 688. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~18~F~3~N~2~O~3~, 475.0; found, 475.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~18~F~3~N~2~O~3~, 475.1264; found, 475.1266.

### (*Z*)-2-(4-Cyano-2-(4-nitrophenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3f** {#sec4.3.6}

Yellow solid (82 mg, 53% yield). mp 228--231 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.83 (s, 1H), 8.30 (d, *J* = 8.9 Hz, 2H), 8.03 (d, *J* = 7.8 Hz, 2H), 7.95 (d, *J* = 8.9 Hz, 2H), 7.53 (d, *J* = 5.1 Hz, 3H), 7.36--7.26 (m, 3H), 7.20 (t, *J* = 7.5 Hz, 2H), 5.51 (s, 2H). ^13^C NMR (CDCl~3~, 125 MHz): δ 175.6, 172.9, 159.8, 147.8, 147.4, 134.2, 133.9, 131.3, 130.7, 129.3, 128.2, 127.7, 126.9, 125.71, 125.4, 124.5, 121.3, 112.8, 97.8, 90.6. IR (CHCl~3~, cm^--1^) ν: 3349, 2923, 2852, 2229, 1600, 1520, 1491, 1446, 1418, 1343, 1110, 938, 853, 756, 693. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~N~3~O~5~, 452.0; found, 452.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~18~N~3~O~5~, 452.1241; found, 452.1216.

### (*Z*)-2-(2-(Benzo\[*d*\]\[1,3\]dioxol-5-yl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacryl amide **3g** {#sec4.3.7}

White solid (105 mg, 68% yield). mp 223--226 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.72 (s, 1H), 7.96 (d, *J* = 6.7 Hz, 2H), 7.51--7.43 (m, 3H), 7.42--7.34 (m, 3H), 7.32--7.27 (m, 2H), 7.22 (t, *J* = 7.4 Hz, 2H), 6.90 (d, *J* = 8.2 Hz, 1H), 6.04 (s, 2H), 5.48 (s, 2H). ^13^C NMR (CDCl~3~, 125 MHz): δ 174.9, 173.3, 157.7, 150.1, 148.6, 148.4, 134.5, 130.4, 129.1, 128.0, 127.9, 127.5, 125.2, 122.5, 119.7, 116.1, 113.4, 109.1, 105.4, 101.6, 97.0, 91.3. IR (CHCl~3~, cm^--1^) ν: 3386, 2923, 2852, 2228, 1642, 1448, 1446, 1418, 1253, 1035, 938, 853, 755, 690. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~19~N~2~O~5~, 451.0; found, 451.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~19~N~2~O~5~, 451.1288; found, 451.1289.

### (*Z*)-2-(4-Cyano-2-(4-hydroxyphenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3h** {#sec4.3.8}

Pale brownish solid (84 mg, 58% yield). mp 232--235 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 16.69 (s, 1H), 8.90 (br s, 1H), 8.02 (d, *J* = 7.6 Hz, 2H), 7.76 (d, *J* = 8.4 Hz, 2H), 7.56--7.43 (m, 5H), 7.30--7.25 (m, 2H), 7.05--6.92 (m, 3H). ^13^C NMR (acetone-*d*~6~, 100 MHz): δ 174.5, 173.9, 158.4, 156.8, 151.3, 135.5, 131.8, 130.0, 129.8, 129.2, 128.1, 127.8, 127.7, 126.9, 124.8, 120.8, 115.9, 113.8, 97.4, 92.0. IR (CHCl~3~, cm^--1^) ν: 3349, 2923, 2852, 2229, 1600, 1520, 1446, 1418, 1343, 1110, 938, 853, 756, 693; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~19~N~2~O~4~, 423.1339; found, 423.1344.

### (*Z*)-2-(4-Cyano-2-(3,4-dimethylphenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3i** {#sec4.3.9}

White solid (92 mg, 62% yield). mp 231--234 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.71 (s, 1H), 7.98 (d, *J* = 6.8 Hz, 2H), 7.59 (d, *J* = 4.8 Hz, 2H), 7.49--7.40 (m, 5H), 7.29 (t, *J* = 8.8 Hz, 1H), 7.30--7.27 (m, 2H), 5.46 (s, 2H), 2.33 (s, 3H), 2.31 (s, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 174.8, 173.4, 157.9, 150.7, 138.4, 137.5, 134.7, 130.4, 130.37, 130.32, 129.1, 128.06, 128.03, 127.6, 126.1, 126.0, 125.3, 122.6, 116.6, 113.5, 97.0, 91.5, 20.0, 19.7. IR (CHCl~3~, cm^--1^) ν: 3347, 3019, 2921, 2851, 2227, 1643, 1573, 1492, 1448, 1445, 1327, 1150, 954, 853, 756, 689. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~23~N~2~O~3~, 435.0; found, 435.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~23~N~2~O~3~, 435.1703; found, 435.1699.

### (*Z*)-2-(4-Cyano-5-phenyl-2-(*p*-tolyl)furan-3-yl)-3-hydroxy-3-phenylacrylamide **3j** {#sec4.3.10}

White solid (103 mg, 73% yield). mp 254--256 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.73 (s, 1H), 8.00 (t, *J* = 8.4 Hz, 2H), 7.76 (d, *J* = 8.0 Hz, 2H), 7.50--7.40 (m, 5H), 7.30--7.27 (m, 3H), 7.23 (d, *J* = 7.6 Hz, 2H), 5.44 (s, 2H), 2.42 (s, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 174.9, 173.4, 158.0, 150.6, 139.6, 130.4, 130.3, 129.9, 129.1, 128.03, 128.01, 125.7, 125.3, 125.0, 116.7, 113.4, 97.0, 91.4, 21.4. IR (CHCl~3~, cm^--1^) ν: 3458, 3310, 2921, 2851, 2224, 1648, 1572, 1446, 1411, 1322, 1114, 937, 770, 687. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~21~N~2~O~3~, 421.0; found, 421.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~21~N~2~O~3~, 421.1547; found, 421.1527.

### (*Z*)-2-(4-Cyano-5-phenyl-2-(*o*-tolyl)furan-3-yl)-3-hydroxy-3-phenylacrylamide **3k** {#sec4.3.11}

White solid (93 mg, 62% yield). mp 234--236 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.47 (s, 1H), 8.01 (d, *J* = 8.2 Hz, 2H), 7.55--7.43 (m, 3H), 7.30--7.24 (m, 3H), 7.18--7.12 (m, 3H), 7.08 (t, *J* = 9.3 Hz, 3H), 5.56 (s, 2H), 1.97 (s, 3H). ^13^C NMR (125 MHz, CDCl~3~): δ 175.4, 173.9, 159.0, 152.9, 137.1, 134.9, 130.9, 130.5, 129.87, 129.85, 129.7, 129.2, 129.1, 128.6, 127.92, 127.91, 127.6, 126.0, 125.2, 118.6, 114.0, 95.8, 91.3, 20.2. IR (CHCl~3~, cm^--1^) ν: 3417, 2924, 2852, 2226, 1643, 1448, 1418, 1326, 1180, 938, 829, 768, 691; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~21~N~2~O~3~, 4218.1543; found, 421.1496.

### (*Z*)-2-(4-Cyano-2-(4-ethylphenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide **3l** {#sec4.3.12}

White solid (112 mg, 75% yield). mp 239--242 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.65 (s, 1H), 7.92 (d, *J* = 8.4 Hz, 2H), 7.70 (d, *J* = 8.4 Hz, 2H), 7.42--7.36 (m, 3H), 7.34 (d, *J* = 7.2 Hz, 2H), 7.22--7.18 (m, 3H), 7.14 (t, *J* = 8.0 Hz, 2H), 5.46 (s, 2H), 2.66 (q, *J* = 7.6 Hz, 2H), 1.22 (t, *J* = 8.4 Hz, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 174.8, 173.9, 158.0, 150.6, 145.9, 134.6, 130.9, 130.3, 129.1, 128.7, 127.6, 125.9, 125.3, 125.1, 116.7, 113.5, 97.0, 91.5, 28.7, 15.2. IR (CHCl~3~, cm^--1^) ν: 3469, 3337, 3188, 3063, 2966, 2931, 2227, 1644, 1572, 1491, 1445, 1415, 1328, 1286, 1151, 938, 837, 767, 689. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~23~N~2~O~3~, 435.0; found, 435.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~23~N~2~O~3~, 435.1703; found, 435.1691.

### (*Z*)-2-(4-Cyano-2-phenyl-5-(*p*-tolyl)furan-3-yl)-3-hydroxy-3-(*p*-tolyl)acrylamide **3m** {#sec4.3.13}

White solid (107 mg, 72% yield). mp 202--205 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.73 (s, 1H), 7.92 (d, *J* = 8.4 Hz, 2H), 7.86 (d, *J* = 8.8 Hz, 2H), 7.49 (t, *J* = 7.2 Hz, 2H), 7.41 (t, *J* = 7.2 Hz, 1H), 7.32 (m, 4H), 7.01 (t, *J* = 8.4 Hz, 2H), 5.44 (s, 2H), 2.42 (m, 3H), 2.42 (m, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.0, 173.4, 158.6, 149.8, 141.0, 140.6, 131.8, 129.8, 129.1, 128.7, 128.6, 127.9, 125.4, 124.99, 124.94, 117.7, 113.5, 96.4, 90.9, 21.5, 21.3. IR (CHCl~3~, cm^--1^) ν: 3469, 3337, 3188, 3063, 2966, 2931, 2227, 1644, 1572, 1491, 1445, 1415, 1328, 1286, 1151, 938, 837, 767, 689. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~23~N~2~O~3~, 435.0; found, 435.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~22~N~2~O~3~, 435.1703; found, 435.1721.

### (*Z*)-3-(4-Bromophenyl)-2-(5-(4-bromophenyl)-4-cyano-2-phenylfuran-3-yl)-3-hydroxyacryl amide **3n** {#sec4.3.14}

Pale yellow solid (135 mg, 70% yield). mp 207--210 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.79 (s, 1H), 7.87 (d, *J* = 8.4 Hz, 2H), 7.80 (d, *J* = 7.2 Hz, 2H), 7.63 (d, *J* = 8.4 Hz, 2H), 7.49 (m, 3H), 7.34 (d, *J* = 8.4 Hz, 2H), 7.23 (d, *J* = 8.4 Hz, 2H), 5.53 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 173.8, 173.1, 157.4, 150.7, 133.4, 132.5, 131.4, 129.7, 129.5, 129.3, 128.1, 126.7, 126.2, 126.1, 125.1, 125.0, 117.2, 113.1, 97.3, 91.4. IR (CHCl~3~, cm^--1^) ν: 3345, 2923, 2852, 2227, 1620, 1483, 1419, 1323, 1152, 1071, 935, 828, 758, 690. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~17~Br~2~N~2~O~3~, 564.0; found, 564.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~17~Br~2~N~2~O~3~, 562.9600; found, 562.9579.

### (*Z*)-3-(3-Chlorophenyl)-2-(5-(3-chlorophenyl)-4-cyano-2-phenylfuran-3-yl)-3-hydroxyacryl amide **3o** {#sec4.3.15}

Pale yellow solid (107 mg, 65% yield). mp 188--190 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.74 (s, 1H), 7.93 (s, 1H), 7.91 (t, *J* = 6.0 Hz, 1H), 7.79 (d, *J* = 7.2 Hz, 2H), 7.50--7.42 (m, 5H), 7.34 (s, 1H), 7.26 (d, *J* = 7.2 Hz, 1H), 7.18 (d, *J* = 7.6 Hz, 1H), 7.12 (t, *J* = 8.0 Hz, 1H), 5.59 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 173.4, 173.2, 156.8, 151.3, 136.1, 135.4, 134.2, 130.6, 130.5, 130.4, 129.8, 129.3, 129.1, 128.9, 128.1, 128.0, 125.9, 125.2, 123.5, 117.0, 112.9, 97.9, 91.8. IR (CHCl~3~, cm^--1^) ν: 3345, 3069, 3021, 2923, 2852, 2229, 1643, 1553, 1475, 1426, 1322, 1156, 942, 756, 694. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~17~Cl~2~N~2~O~3~, 475.0; found, 475.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~17~Cl~2~N~2~O~3~, 475.0611; found, 475.0594.

### (*Z*)-3-(4-Chlorophenyl)-2-(5-(4-chlorophenyl)-4-cyano-2-phenylfuran-3-yl)-3-hydroxyacryl amide **3p** {#sec4.3.16}

Pale brownish solid (117 mg, 72% yield). mp 210--213 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.77 (s, 1H), 7.96 (t, *J* = 8.8 Hz, 2H), 7.82 (d, *J* = 7.2 Hz, 2H), 7.51--7.41 (m, 5H), 7.33 (d, *J* = 7.6 Hz, 2H), 7.20 (d, *J* = 8.4 Hz, 2H), 5.52 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 173.8, 173.1, 157.3, 150.6, 136.8, 133.0, 129.6, 129.5, 129.3, 128.4, 128.1, 126.6, 125.8, 125.0, 117.2, 113.1, 97.3, 91.4. IR (CHCl~3~, cm^--1^) ν: 3339, 2921, 2851, 2228, 1642, 1486, 1419, 1324, 1271, 1093, 1013, 935, 833, 757, 691. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~17~Cl~2~N~2~O~3~, 475.0; found, 475.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~17~Cl~2~N~2~O~3~, 475.0611; found, 475.0586.

### (*Z*)-2-(2-(3-Bromophenyl)-4-cyano-5-(*p*-tolyl)furan-3-yl)-3-hydroxy-3-(*p*-tolyl)acrylamide **3q** {#sec4.3.17}

White solid (113 mg, 65% yield). mp 222--235 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.64 (s, 1H), 7.82 (d, *J* = 8.0 Hz, 2H), 7.74 (dd, *J* = 5.6, 2.4 Hz, 2H), 7.22--7.18 (m, 5H), 7.09 (t, *J* = 8.4 Hz, 2H), 6.90 (d, *J* = 8.0 Hz, 2H), 5.38 (s, 2H), 2.34 (s, 3H), 2.18 (s, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.2, 173.4, 158.7, 149.0, 141.1, 140.7, 131.7, 129.8, 128.7, 127.9, 127.08, 127.00, 125.3, 124.8, 117.3, 116.4, 116.2, 113.5, 96.4, 90.6, 21.5, 21.3. IR (CHCl~3~, cm^--1^) ν: 3346, 3206, 2922, 2851, 2227, 1642, 1614, 1504, 1418, 1328, 1184, 1150, 1116, 1020, 941, 821, 763, 688. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~21~BrN~2~O~3~, 513.0, 515.0; found, 513.0, 515.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~21~BrN~2~O~3~, 513.0808, 515.0788; found, 513.0793, 515.0783.

### (*Z*)-2-(4-Cyano-2,5-di-*p*-tolylfuran-3-yl)-3-hydroxy-3-(*p*-tolyl)acrylamide **3r** {#sec4.3.18}

White solid (115 mg, 74% yield). mp 214--216 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.72 (s, 1H), 7.91 (d, *J* = 8.0 Hz, 2H), 7.77 (d, *J* = 8.0 Hz, 2H), 7.34--7.27 (m, 7H), 7.02 (d, *J* = 8.0 Hz, 2H), 5.47 (s, 2H), 2.427 (s 3H), 21.421 (s, 3H), 2.27 (s, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 174.8, 173.5, 158.3, 150.0, 140.9, 140.6, 139.4, 131.8, 129.89, 129.81, 128.7, 128.0, 125.9, 125.3, 125.0, 124.9, 116.9, 113.6, 96.3, 91.0, 21.8, 21.39, 21.38. IR (CHCl~3~, cm^--1^) ν: 3342, 3031, 2922, 2852, 2227, 1643, 1613, 1504, 1418, 1329, 1184, 1116, 941, 821, 758, 688. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~29~H~25~N~2~O~3~, 449.0; found, 449.0; HRMS (TOF) *m*/*z*: \[M + Na\]^+^ calcd for C~29~H~24~N~2~NaO~3~, 471.1679; found, 471.1674.

### (*Z*)-3-(4-Bromophenyl)-2-(5-(4-bromophenyl)-2-(4-chlorophenyl)-4-cyanofuran-3-yl)-3-hydroxyacrylamide **3s** {#sec4.3.19}

Pale brown solid (138 mg, 68% yield). mp 203--206 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.70 (s, 1H), 7.79 (d, *J* = 8.4 Hz, 2H), 7.66 (d, *J* = 8.8 Hz, 2H), 7.42--7.36 (m, 3H), 7.34 (d, *J* = 7.2 Hz, 2H), 7.22--7.18 (m, 3H), 7.14 (t, *J* = 8.0 Hz, 2H), 5.46 (s, 2H), 2.66 (q, *J* = 7.6 Hz, 2H), 1.22 (t, *J* = 8.4 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 174.1, 173.0, 157.6, 149.6, 135.8, 133.2, 132.5, 131.5, 129.6, 129.4, 126.8, 126.5, 126.2, 126.0, 125.3, 125.1, 117.6, 112.9, 97.4, 91.1. IR (CHCl~3~, cm^--1^) ν: 3356, 2923, 2851, 2228, 1649, 1483, 1419, 1323, 1010, 935, 830, 762. LC-MS (ESI) *m*/*z*: \[M -- H\]^+^ calcd for C~26~H~14~Br~2~ClN~2~O~3~, 595.0, 597.0; found, 595.0, 597.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~16~Br~2~ClN~2~O~3~, 596.9211, 598.9190; found, 596.9212, 598.9193.

### (*Z*)-2-(4-Cyano-2-(4-fluorophenyl)-5-(*p*-tolyl)furan-3-yl)-3-hydroxy-3-(*p*-tolyl)acrylamide **3t** {#sec4.3.20}

White solid (98 mg, 63% yield). mp 212--215 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.64 (s, 1H), 7.82 (d, *J* = 8.0 Hz, 2H), 7.74 (dd, *J* = 5.6, 2.4 Hz, 2H), 7.22--7.18 (m, 5H), 7.09 (t, *J* = 8.4 Hz, 2H), 6.90 (d, *J* = 8.0 Hz, 2H), 5.38 (s, 2H), 2.34 (s, 3H), 2.18 (s, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.2, 173.4, 158.7, 149.0, 141.1, 140.7, 131.7, 129.8, 128.7, 127.9, 127.08, 127.00, 125.3, 124.8, 117.3, 116.4, 116.2, 113.5, 96.4, 90.6, 21.5, 21.3. IR (CHCl~3~, cm^--1^) ν: 3477, 3345, 3196, 2922, 2852, 2226, 1615, 1500, 1417, 1327, 1235, 1159, 1020, 935, 838, 756, 667. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~22~FN~2~O~3~, 453.0; found, 453.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~28~H~22~FN~2~O~3~, 453.1609; found, 453.1649.

### (*Z*)-3-(4-Chlorophenyl)-2-(5-(4-chlorophenyl)-4-cyano-2-(*p*-tolyl)furan-3-yl)-3-hydroxyacryl amide **3u** {#sec4.3.21}

Pale brown solid (110 mg, 65% yield). mp 210--212 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.66 (s, 1H), 7.86 (d, *J* = 8.8 Hz, 2H), 7.64 (d, *J* = 8.0 Hz, 2H), 7.39 (d, *J* = 8.8 Hz, 2H), 7.25--7.18 (m, 4H), 7.11 (d, *J* = 8.8 Hz, 2H), 5.47 (s, 2H), 2.34 (s, 3H). ^13^C NMR (CDCl~3~, 100 MHz): δ 173.6, 173.2, 157.0, 150.9, 140.0, 136.6, 136.5, 133.0, 130.0, 129.5, 129.4, 128.4, 126.5, 125.9, 125.0, 116.4, 113.2, 97.2, 91.6, 21.4. IR (CHCl~3~, cm^--1^) ν: 3473, 3346, 3202, 2922, 2852, 2227, 1642, 1486, 1418, 1325, 1178, 1093, 1013, 935, 832, 757, 677. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~19~ClN~2~O~3~, 489.0; found, 489.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~27~H~19~ClN~2~O~3~, 489.0767; found, 489.0807.

### (*Z*)-2-(4-Cyano-5-phenyl-2-(thiophen-2-yl)furan-3-yl)-3-hydroxy-3-phenylacrylamide **3v** {#sec4.3.22}

Pale brown solid (65 mg, 46% yield). mp 189--191 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.74 (s, 1H), 7.98 (d, *J* = 7.2 Hz, 2H), 7.72 (s, 1H), 7.51--7.44 (m, 5H), 7.40 (d, *J* = 7.2 Hz, 2H), 7.29 (t, *J* = 8.4 Hz, 1H), 7.23 (t, *J* = 7.2 Hz, 2H), 5.50 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 175.4, 173.4, 157.9, 148.3, 134.5, 130.5, 130.4, 129.5, 129.1, 128.4, 128.09, 128.00, 127.8, 127.2, 125.3, 124.6, 122.9, 116.2, 113.4, 96.6, 90.8. IR (CHCl~3~, cm^--1^) ν: 3346, 3110, 2924, 2853, 2228, 1667, 1509, 1448, 1415, 1264, 1178, 1074, 929, 842, 756, 690; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~17~N~2~O~3~S, 413.0954; found, 413.0956.

### (*Z*)-2-(2-(5-Chlorothiophen-2-yl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacryl amide **3w** {#sec4.3.23}

White solid (83 mg, 55% yield). mp 203--206 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 15.86 (s, 1H), 7.97 (d, *J* = 7.7 Hz, 2H), 7.53--7.45 (m, 3H), 7.41 (d, *J* = 7.3 Hz, 2H), 7.34--7.28 (m, 1H), 7.29--7.19 (m, 3H), 6.93 (d, *J* = 3.9 Hz, 1H), 5.50 (s, 1H). ^13^C NMR (101 MHz, CDCl~3~): δ 176.3, 173.2, 158.3, 146.4, 134.4, 132.7, 130.8, 130.6, 129.2, 128.2, 128.1, 127.8, 127.1, 126.9, 125.4, 124.6, 116.3, 113.2, 96.8, 89.8. IR (CHCl~3~, cm^--1^) ν: 3395, 2921, 2851, 2229, 1649, 1454, 1415, 1267, 1146, 1114, 980, 771, 672. LC-MS (ESI) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~16~ClN~2~O~3~S, 447.0; found, 447.0; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~16~ClN~2~O~3~S, 447.0565; found, 447.0551.

### (*Z*)-2-(2-(5-Bromothiophen-2-yl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacryl amide **3x** {#sec4.3.24}

Pale brown solid (108 mg, 65% yield). mp 190--194 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.91 (s, 1H), 8.01 (d, *J* = 8.4 Hz, 2H), 7.45 (d, *J* = 7.2 Hz, 2H), 7.36 (t, *J* = 7.2 Hz, 1H), 7.29 (d, *J* = 8.8 Hz, 2H), 7.25 (d, *J* = 4.0 Hz, 1H), 7.10 (d, *J* = 4.0 Hz, 1H), 5.46 (s, 2H). ^13^C NMR (CDCl~3~, 100 MHz): δ 176.3, 173.2, 158.3, 146.4, 134.4, 131.1, 130.8, 130.7, 130.6, 129.2, 128.1, 127.8, 127.1, 125.5, 125.4, 116.5, 115.2, 113.2, 96.8, 89.8. IR (CHCl~3~, cm^--1^) ν: 3345, 3194, 3059, 2923, 2851, 2228, 1643, 1572, 1490, 1444, 1406, 1328, 1263, 1150, 1028, 967, 798, 768, 688; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~16~BrN~2~O~3~S, 491.0060, 493.0039; found, 490.9960, 492.9952.

### (*Z*)-2-(2-(5-Bromothiophen-2-yl)-4-cyano-5-(*p*-tolyl)furan-3-yl)-3-hydroxy-3-(*p*-tolyl)acryl amide **3y** {#sec4.3.25}

White solid (110 mg, 63% yield). mp 233--236 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.90 (s, 1H), 7.91 (d, *J* = 8.0 Hz, 2H), 7.35 (m, 4H), 7.24 (d, *J* = 4.0 Hz, 1H), 7.09--7.05 (m, 3H), 5.40 (s, 2H), 2.45 (s, 3H), 2.30 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 176.3, 173.2, 141.4, 140.9, 131.3, 130.6, 129.9, 128.8, 127.8, 125.3, 125.2, 124.5, 119.4, 115.0, 113.4, 96.1, 94.7, 21.6, 21.4. IR (CHCl~3~, cm^--1^) ν: 3362, 2922, 2851, 2229, 1681, 1605, 1503, 1453, 1250, 1185, 976, 869, 820, 754, 720, 673; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~26~H~20~BrN~2~O~3~S, 519.0373, 521.0352; found, 519.0327, 521.0313.

### (*Z*)-2-(2-(5-Bromothiophen-2-yl)-5-(4-chlorophenyl)-4-cyanofuran-3-yl)-3-(4-chlorophenyl)-3-hydroxyacrylamide **3z** {#sec4.3.26}

Pale brown solid (99 mg, 53% yield). mp 235--238 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.92 (s, 1H), 7.92 (d, *J* = 8.4 Hz, 2H), 7.48 (d, *J* = 8.8 Hz, 2H), 7.34 (d, *J* = 8.8 Hz, 2H), 7.23--7.21 (m, 3H), 7.08 (d, *J* = 3.6 Hz, 1H), 5.46 (s, 2H). ^13^C NMR (100 MHz, CDCl~3~): δ 175.1, 173.0, 157.3, 146.7, 137.0, 136.8, 132.7, 130.8, 130.6, 129.6, 129.2, 128.6, 126.6, 125.8, 125.4, 116.0, 115.7, 112.9, 96.9, 89.9. IR (CHCl~3~, cm^--1^) ν: 3334, 2957, 2924, 2852, 2230, 1649, 1589, 1486, 1405, 1320, 1259, 1174, 1093, 1013, 980, 834, 757, 610; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~14~BrCl~2~N~2~O~3~S, 558.9280, 560.9260; found, 558.9204, 560.9211.

### (*Z*)-3-(4-Bromophenyl)-2-(5-(4-bromophenyl)-2-(5-bromothiophen-2-yl)-4-cyanofuran-3-yl)-3-hydroxyacrylamide **3aa** {#sec4.3.27}

White solid (128 mg, 58% yield). mp 252--255 °C. ^1^H NMR (CDCl~3~, 400 MHz): δ 15.93 (s, 1H), 7.84 (d, *J* = 8.8 Hz, 2H), 7.64 (d, *J* = 8.8 Hz, 2H), 7.39 (d, *J* = 8.8 Hz, 1H), 7.27--7.25 (m, 5H), 7.22 (d, *J* = 4.0 Hz, 1H), 5.39 (s, 2H). ^13^C NMR (126 MHz, acetone-*d*~6~): δ 174.3, 174.0, 156.9, 146.7, 134.2, 131.4, 131.4, 131.1, 129.6, 126.8, 126.6, 126.1, 124.3, 124.2, 116.6, 114.1, 113.2, 97.6, 90.3, 78.3. IR (CHCl~3~, cm^--1^) ν: 3396, 2921, 2850, 2227, 1649, 1454, 1249, 1215, 1010, 827, 755, 666; HRMS (TOF) *m*/*z*: \[M + H\]^+^ calcd for C~24~H~14~Br~3~N~2~O~3~S, 648.8249, 650.8229; found, 648.8193, 650.8179.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b00715](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b00715).Experimental procedures, details for control experiments, characterization data, and ^1^H and ^13^C NMR spectra ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00715/suppl_file/ao8b00715_si_001.pdf))X-ray crystallographic data for **3f** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00715/suppl_file/ao8b00715_si_002.cif))X-ray crystallographic data for **3n** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00715/suppl_file/ao8b00715_si_003.cif))
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